Kevin L. Mensink is President & VP at ENTELLUS MEDICAL INC (ENTL). They have made 4 open-market trades across 1 company since 2016, most recently 2017-10-20.
CIK 0001374128
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENTL | 7,500 | $67K |
Shares reported on the most recent Form 4, priced at the 2017-10-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENTL | SELL · 10b5-1 | 2017-10-20 | 2017-10-24 | $19.00 | $48K | -4.4% | -11.4% | +33.3% |
| ENTL | SELL | 2017-10-16 | 2017-10-18 | $18.29 | $183K | -6.9% | -14.4% | +29.1% |
| ENTL | SELL | 2016-09-01 | 2016-09-01 | $18.39 | $147K | -0.7% | +17.7% | -1.6% |
| ENTL | SELL | 2016-08-01 | 2016-08-02 | $17.63 | $143K | +2.8% | +6.3% | +15.9% |
| ENTL | SELL | 2016-08-01 | 2016-08-02 | $17.63 | $143K | +2.8% | +6.3% | +15.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.